Ancora Pharmaceuticals Inc.

 

Enabling Carbohydrate-Based Product Discovery

 

Ancora’s cutting edge technology enables the rapid,
milligram to kilogram production of synthetic
carbohydrates for use in drug discovery and

industrial applications. 

 

Utilizing a unique array of functionalized building blocks and

assembly capabilities, Ancora can efficiently construct a wide

variety of complex oligosaccharide structures, directly addressing a
long-standing bottleneck in carbohydrate based product discovery. 

 

           Ancora is developing unique carbohydrate-based

            therapeutics including immunomodulatory drugs

            such as vaccines and therapeutics to treat cardiovascular and metabolic disease. 
Ancora also works with pharmaceutical and industrial partners to provide customized
carbohydrate material.

 

For more information on Ancora or its synthetic solutions, please contact:

John Pena, Ph.D.  200 Boston Avenue, Suite 4975, Medford, MA 02155

(781) 395-7700; info@ancorapharma.com